OA10.06 Impact of Brain Metastases on Safety and Efficacy of MK-6070, a DLL3-Targeting T Cell Engager, in Small Cell Lung Cancer
Noura J. Choudhury(University of Chicago Medicine Comprehensive Cancer Center), Prantesh Jain(Roswell Park Comprehensive Cancer Center), Hirva Mamdani(Wayne State University), A. Dowlati(University Hospitals of Cleveland), Jonathan R. Thompson, Himisha Beltran(Dana-Farber Cancer Institute), M.L. Johnson(Sarah Cannon), Erin L. Schenk(University of Colorado Anschutz Medical Campus), Rachel E. Sanborn(Providence Portland Medical Center), Rahul Aggarwal(UCSF Helen Diller Family Comprehensive Cancer Center), Ann W. Gramza(Rapt Therapeutics (United States))
Cited by 12
Related Papers
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Personalized <i>In Vitro</i> and <i>In Vivo</i> Cancer Models to Guide Precision Medicine
|Cancer Discovery|2017|964
Immunotherapy in Lung Cancer: Current Landscape and Future Directions
|Frontiers in Immunology|2022|373